Status:
WITHDRAWN
Identification of Autoantibodies and Autoantigens in the Cerebrospinal Fluid of Patients With Spinal Cord Trauma
Lead Sponsor:
University Hospital, Lille
Conditions:
Bone Marrow Failure
Trauma
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to detect the presence of autoantibodies and autoantigens in cerebrospinal fluid early (\<48 hours) following spinal cord trauma. The study also aims to define the central...
Eligibility Criteria
Inclusion
- Patients with spinal cord injury dating back less than 48 hours
- Men or women over 18 years of age
- Patients benefiting from social protection
- Surgery performed within 48 hours of the trauma
- Informed and signed consent by the patient or trusted person
Exclusion
- Contra-indication to ensure surgical decompression within the first 48 hours following the trauma
- Coagulation disorders or any condition that may make the lumbar puncture risky (eg, history of lumbar surgery)
- Severe cranial trauma associated
- History of autoimmune pathology
- Immunosuppressive therapy or long-term corticosteroid therapy
- Patients unable to comply with protocol requirements
- Person benefiting from legal protection (guardianship / curator)
- Person deprived of liberty
- Patient unable to express consent
- Pregnant women
Key Trial Info
Start Date :
September 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03249129
Start Date
September 1 2018
End Date
April 1 2021
Last Update
December 5 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.